{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:13:08Z","timestamp":1789726388549,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ejogrb.2019.05.013","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:23:20Z","timestamp":1557833000000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"238","author":[{"given":"Shrouk M.","family":"Elghazaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M.","family":"Hamam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Badawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim Aiman","family":"Yakoub Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Samy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2019.05.013_bib0005","first-page":"167","article-title":"Prevalence of bacterial vaginosis among women in Delhi, India","volume":"125","author":"Bhalla","year":"2007","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/IJWH.S23814","article-title":"Antibacterial treatment of bacterial vaginosis: current and emerging therapies","volume":"3","author":"Menard","year":"2011","journal-title":"Int J Women\u2019s Health"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","article-title":"Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations","volume":"74","author":"Amsel","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/sti.54.2.77","article-title":"Secnidazole. A 5-nitroimidazole derivative with a long half-life","volume":"54","author":"Videau","year":"1978","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","article-title":"Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials","volume":"36","author":"Lamp","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/705692","article-title":"Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole","volume":"2010","author":"Bohbot","year":"2010","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0035","first-page":"32","article-title":"Sexually transmitted diseases treatment guidelines 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR"},{"issue":"151","key":"10.1016\/j.ejogrb.2019.05.013_bib0040","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"18","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0050","first-page":"3","article-title":"Cochrane Handbook: Cochrane Reviews: Ch 8: Assessing risk of bias in included studies","author":"Green","year":"2011","journal-title":"Cochrane Handb Syst Rev Interv"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0060","first-page":"771","article-title":"A single dose of 2 g secnidazole in the treatment of bacterial vaginosis and trichomonas vaginitis","volume":"39","author":"Ndoye","year":"1992","journal-title":"Med Afr Noire"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0065","first-page":"171","article-title":"Nonspecific vaginitis: secnidazole and metronidazole comparative treatment","volume":"98","author":"Bagnoli","year":"1989","journal-title":"Folha Med"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0070","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ajog.2015.09.013","article-title":"A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis","volume":"213","author":"Hillier","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0075","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ajog.2016.09.017","article-title":"A phase 3 randomized, double-blind, placebo-controlled study to confirm the efficacy and safety of a single, oral dose of SYM-1219, a granule formulation containing 2 grams of secnidazole, for the treatment of bacterial vaginosis","volume":"215","author":"Schwebke","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0080","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/jwh.2017.6500","article-title":"A phase 3, multicenter, prospective, open-label study to evaluate the safety of a single dose of secnidazole 2 g for the treatment of women and postmenarchal adolescent girls with bacterial vaginosis","volume":"27","author":"Chavoustie","year":"2018","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.08.017","article-title":"A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis","volume":"217","author":"Schwebke","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0090","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s12325-016-0411-9","article-title":"Lack of a pharmacokinetic interaction between SYM-1219 granules containing 2 grams of secnidazole and a combined oral contraceptive in a phase 1, randomized, open-label study in healthy female volunteers","volume":"33","author":"Pentikis","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/cpdd.406","article-title":"Two phase 1, open\u2010label, single\u2010dose, randomized, crossover studies to assess the pharmacokinetics, safety, and tolerability of orally administered granules of secnidazole (2 g) in healthy female volunteers under different administration conditions","volume":"7","author":"Pentikis","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1590\/S1984-82502009000400011","article-title":"Bioavailability of two oral formulas of secnidazole in healthy volunteers","volume":"45","author":"Montovani","year":"2009","journal-title":"Braz J Pharm Sci"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.18597\/rcog.77","article-title":"Effectiveness and safety of the combination of fluconazole and secnidazole for the treatment of symptomatic vaginal discharge: Bogot\u00e1, Colombia","volume":"65","author":"\u00c1ngel-M\u00fcller","year":"2014","journal-title":"Rev Colomb Obstet Ginecol"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0110","first-page":"E473","article-title":"Comparison of single dose oral secnidazole with multiple doses of intravaginal clindamycin for symptomatic bacterial vaginosis in randomised controlled trial","author":"Tariq","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0020-7292(98)00029-0","article-title":"Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole","volume":"62","author":"Sara\u00e7o\u011flu","year":"1998","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijgo.2004.11.028","article-title":"Low-dose secnidazole in the treatment of bacterial vaginosis","volume":"88","author":"N\u00fa\u00f1ez","year":"2005","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/0253-7613.93859","article-title":"A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis","volume":"44","author":"Thulkar","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/AOG.0000000000002135","article-title":"Secnidazole treatment of bacterial vaginosis: a randomized controlled trial","volume":"130","author":"Hillier","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0135","first-page":"686","article-title":"Treatment for symptomatic bacterial vaginosis: a randomized controlled trial","volume":"27","author":"Tariq","year":"2017","journal-title":"J College Phys Surgeons--Pak JCPSP"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1517\/14656566.2014.881800","article-title":"Treatment of bacterial vaginosis: what we have and what we miss","volume":"15","author":"Donders","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijgo.2012.08.022","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of rifaximin for the treatment of bacterial vaginosis","volume":"120","author":"Donders","year":"2013","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2019.05.013_bib0150","doi-asserted-by":"crossref","first-page":"e00262","DOI":"10.1128\/mSphereDirect.00262-18","article-title":"Metatranscriptome analysis of the vaginal microbiota reveals potential mechanisms for protection against metronidazole in bacterial vaginosis","volume":"3","author":"Deng","year":"2018","journal-title":"mSphere"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211519302325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211519302325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:45:53Z","timestamp":1759556753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211519302325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":30,"alternative-id":["S0301211519302325"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2019.05.013","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2019.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}